Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients

Clinical Rheumatology

Volumn 33, Issue 9, 2014, Pages 1263-1271

  Quaglia, Marco ^a,b   Chiocchetti, Annalisa ^a,b   Cena, Tiziana ^a   Musetti, Claudio ^a   Monti, Sara ^a   Clemente, Nausicaa ^a,b   Dianzani, Umberto ^a,b   Magnani, Corrado ^a   Stratta, Piero ^a,b  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

ACE inhibitors; Glomerular filtration rate; Osteopontin; Proteinuria; Systemic lupus erythematosus

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OSTEOPONTIN;

ADULT; AMERICAN COLLEGE OF RHEUMATOLOGY DAMAGE INDEX; ANEMIA; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMMUNOLOGICAL PARAMETERS; KIDNEY FUNCTION; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS INTERNATIONAL COLLABORATING CLINICS DAMAGE INDEX; BLOOD; CROSS-SECTIONAL STUDY; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OSTEOPONTIN; SEVERITY OF ILLNESS INDEX;

EID: 84906790427     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-014-2665-4     Document Type: Article

References (44)

1. Rangaswami H, Bulbule A, Kundu GC (2006) Osteopontin: role in cell signaling and cancer progression. Trends Cell Biol 16(2):79-87 (Pubitemid 43247403)
2. Lund SA, GiachelliCM, ScatenaM(2009) The role of osteopontin in inflammatory processes. J Cell Commun Signal 3(3-4):311-322
3. Senger DR, Perruzzi CA, Papadopoulos-Sergiou A, Van de Water L (1994) Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain. Mol Biol Cell 5(5):565-574 (Pubitemid 24183445)
4. Yokasaki Y, Sheppard D (2000) Mapping of the cryptic integrin-binding site in osteopontin suggests a new mechanism by which thrombin can regulate inflammation and tissue repair. Trends Cardiovasc Med 10(4):155-159 (Pubitemid 32178192)
5. Yamaguchi Y, Shao Z, Sharif S, Du XY et al (2013) Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage. J Biol Chem 288(5):3097-3111
6. Shao JS, Sierra OL, Cohen R, Mecham RP et al (2011) Vascular calcification and aortic fibrosis: a bifunctional role for osteopontin in diabetic arteriosclerosis. Arterioscler Thromb Vasc Biol 31(8):1821-1833
7. Hamada Y, Yuki K, OkazakiM, FujitaniWet al (2004) Osteopontin-derived peptide SVVYGLR induces angiogenesis in vivo. Dent Mater J 23(4):650-655 (Pubitemid 40353603)
8. Krause SW, Rehli M, Kreutz M, Schwarzfischer L et al (1996) Differential screening identifies genetic markers of monocyte to macrophage maturation. J Leukoc Biol 60:540-545 (Pubitemid 26356781)
9. Shinohara ML, Jansson M, Hwang ES, Werneck MB et al (2005) T-bet-dependent expression of osteopontin contributes to T cell polarization. Proc Natl Acad Sci U S A 102:17101-17106 (Pubitemid 41692690)
10. Kawamura K, Iyonaga K, Ichiyasu H, Nagano J et al (2005) Differentiation, maturation, and survival of dendritic cells by osteopontin regulation. Clin Diagn Lab Immunol 12:206-212
11. Triantafyllopoulou A, Franzke CW, Seshan SV, Perino G et al (2010) Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages. Proc Natl Acad Sci U S A 107:3012-3017
12. Lorenzen J, Shah R, Biser A, Staicu S et al (2008) The role of osteopontin in the development of albuminuria. J Am Soc Nephrol 19(5):884-890
13. Denhardt DT, Noda M, O'Regan AWet al (2001) Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling and cell survival. J Clin Invest 107:1055-1061 (Pubitemid 32422899)
14. Scatena M, Liaw L, Giachelli CM (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 27:2302-2309 (Pubitemid 350203943)
15. Ohmori R, Momiyama Y, Taniguchi H et al (2003) Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis 170:333-337 (Pubitemid 37377807)
16. Kingel K, Kandolf R (2010) Osteopontin: a biomarker to predict the outcome of inflammatory heart disease. Semin Thromb Hemost 36(2):195-202
17. Agnholt J, Kelsen J, Schack L et al (2007) Osteopontin, a protein with cytokine like properties, is associated with inflammation in Crohn's disease. Scand J Immunol 65:453-460 (Pubitemid 46632541)
18. Chiocchetti A, Indelicato M, Bensi T et al (2004) High levels of osteopontin associated with polymorphisms in its gene are a risk factor for development of autoimmunity/lymphoproliferation. Blood 103(4):1376-1382 (Pubitemid 38168652)
19. D'alfonso S, Barizzone N, Giordano M et al (2005) Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthirtis Rheumatol 52(2):539-547 (Pubitemid 40216318)
20. Wong CK, Lit LCW, Tam SL et al (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology 44:602-606 (Pubitemid 41487227)
21. Patarca R, Wei FY, Singh P, Morasso MI et al (1990) Dysregulated expression of the Tcell cytokine Eta-1 in CD4-8- lymphocytes during the development of murine autoimmune disease. J Exp Med 172:1177-1183 (Pubitemid 20343218)
22. Hudkins KL, Giachelli CM, Cui Y, Couser WG et al (1999) Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10(3):444-457 (Pubitemid 29117625)
23. Zhou C, Wu J, Torres L, Hicks JM et al (2010) Blockade of osteopontin inhibits glomerular fibrosis in a model of anti-glomerular basement membrane glomerulonephritis. Am J Nephrol 32(4):324-331
24. Lorenzen J, Krämer R, Kliem V et al (2010) Circulating levels of osteopontin are closely related to glomerular filtration rate and cardiovascular risk markers in patients with chronic kidney disease. Eur J Clin Investig 40(4):294-300
25. Yamaguchi H, Igarashi M, Hirata A et al (2004) Progression of diabetic nephropathy enhances the plasma osteopontin level in type 2 diabetic patients. Endocr J 51(5):499-504 (Pubitemid 39536359)
26. Yan X, Sano M, Lu L et al (2010) Plasma concentrations of osteopontin, but not thrombin-cleaved osteopontin, are associated with the presence and severity of nephropathy and coronary artery disease in patients with type 2 diabetes mellitus. Cardiovasc Diabetol 29:9-70
27. Lorenzen J, Svjetlana L, Krämer R et al (2010) Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy. Ann Rheum Dis 69:1169-1171
28. Okada H, Moriwaki K, Konishi K et al (2000) Tubular osteopontin expression in human glomerulonephritis and renal vasculitis. Am J Kidney Dis 36(3):498-506
29. Ruggenenti P, Cravedi P, Remuzzi G (2012) Mechanisms and treatment of CKD. J Am Soc Nephrol 23(12):1917-1928
30. Xie Y, Sakatsume M, Nishi S et al (2001) Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney Int 60(5):1645-1657 (Pubitemid 32999968)
31. Kramer AB, Ricardo SD, Kelly DJ et al (2005) Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis. J Pathol 207:483-492 (Pubitemid 43025697)
32. Hochberg MC, for theDiagnostic and Therapeutic Criteria Committee of the American College of Rheumatology (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725
33. National Kidney Foundation (2011) http://www.kidney.org/professionals/ kdoqi/guidelines.cfm. Accessed 29 Jun 2011
34. Romero-Diaz J, Isenberg D, Ramsey-Goldman R (2011) Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI). Arthritis Care Res (Hoboken) 63(11):S37-S46
35. Gladman DD, Goldsmith CH, UrowitzMB, Bacon P et al (2000) The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. J Rheumatol 27(2):373-376 (Pubitemid 30095466)
36. Nicholas SB, Liu J, Kim J et al (2010) Critical role for osteopontin in diabetic nephropathy. Kidney Int 77(7):588-600
37. Congote LF, Sadyakassova G, Dobocan MC et al (2010) Erythropoietin- dependent endothelial proteins: potential use against erythropoietin resistance. Cytokine 51(2):113-118
38. Rullo OJ, Woo JM, Parsa MF, Hoftman AD et al (2013) Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther 15(1):R18
39. Koshikawa M, Aizawa K, Kasai H et al (2009) Elevated osteopontin levels in patients with peripheral arterial disease. Angiology 60(1):42-45
40. Cangiano E, Marchesini J, Campo G et al (2011) ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes.AmJ Cardiovasc Drugs 11(3):189-198
41. Kusuyama T, Yoshiyama M, Omura T et al (2005) Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction. J Pharmacol Sci 98(3):283-289 (Pubitemid 41296409)
42. Nemati F, Rahbar-Roshandel N, Hosseini F et al (2011) Anti-inflammatory effects of anti-hypertensive agents: influence on interleukin-1β secretion by peripheral blood polymorphonuclear leukocytes from patients with essential hypertension. Clin Exp Hypertens 33(2):66-76
43. Yu XQ, Wu LL, Huang XR et al (2000) Osteopontin expression in progressive renal injury in remnant kidney: role of angiotensin II. Kidney Int 58(4):1469-1480
44. Li C, Yang CW, Park CW et al (2003) Long-term treatment with Ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int 63(2):454-463 (Pubitemid 36126792)